BSE filing, BSE: 539544. Summary written from the filing by ALFA Finder's alert engine.
More from Abhishek Infraventures Ltd
All →Abhishek Infraventures Other Announcement
Abhishek Infraventures Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, as issued by its RTA.
Abhishek Infraventures Annual General Meeting
Abhishek Infraventures Limited held its 42nd Annual General Meeting on September 29, 2026, where members adopted financial statements and approved the re-appointment of directors.
Abhishek Infraventures Annual General Meeting
Abhishek Infraventures Limited has issued the notice for its 42nd Annual General Meeting, scheduled for September 29, 2026.
Abhishek Infraventures Management Change
Abhishek Infraventures re-appointed Mr. Nagaraju Nookala as Executive Director for a 36-month term, effective March 2, 2027. The decision was ratified by the board.
- Execution
- 36 months
Abhishek Infraventures Q1 FY27 Results: Net Profit ₹0 Cr
Abhishek Infraventures Ltd reported net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Abhishek Infraventures Board Meeting Date
Abhishek Infraventures Limited scheduled a board meeting on August 13, 2026, to consider the company's unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.